The Global Spinal Non-Fusion Devices Market Size is projected to grow at a CAGR of 5.22% during the forecast period from 2024 to 2030 | DelveInsight

The Spinal Non-Fusion Devices market was valued at USD 2,757.17 million in 2023 and is projected to reach USD 3,731.02 million by 2030. Growth is anchored in the rising prevalence of spinal disorders, increasing preference for minimally invasive procedures, and continued product launches and regulatory approvals.

DelveInsight's Spinal Non-Fusion Devices Market Insights Report 2030 provides the current and forecast market analysis, individual leading Spinal Non-Fusion Devices companies' market shares, challenges, Spinal Non-Fusion Devices Market Drivers, barriers, trends, and key market Spinal Non-Fusion Devices companies in the market.

To read more about the latest highlights related to the Spinal Non-Fusion Devices Market @ https://www.delveinsight.com/sample-request/spinal-non-fusion-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Key Takeaways from the Spinal Non Fusion Devices Market Report

- In October 2023, Johnson & Johnson MedTech announced that DePuy Synthes had received 510(k) clearances from the U.S. FDA for the TriALTISTM Spine System and TriALTISTM Navigation Enabled Instruments. Strategic significance: Adds a motion-and-function-preserving spinal system as an alternative to traditional spinal fusion procedures.
- In June 2023, Premia Spine received FDA approval for its Total Posterior Spine (TOPS) facet joint replacement system, after earlier earning Breakthrough Designation status. Strategic significance: Expands facet joint replacement options that preserve anatomical structures removed during spinal decompression.
- In May 2021, Spinal Stabilization Technologies Ltd received Breakthrough Designation and CE mark approval for the PerQdisc Nucleus Replacement System for degenerative disc disease. Strategic significance: PerQdisc is the only commercially available lumbar nucleus replacement system in the world.
- The global Spinal Non-Fusion Devices market is growing at a CAGR of 5.22% during the forecast period from 2024 to 2030.
- The principal drivers are the growing prevalence of spinal disorders, particularly among the aging population; rising incidence of spinal cord injury and lower back pain worldwide; patient preference for treatments that minimize surgical risk and recovery time; and continuous innovation, product launches, and regulatory approvals among leading manufacturers.
- The leading Spinal Non-Fusion Devices Companies include Stryker, NuVasive Inc., Medtronic, Zimmer Biomet, ATEC Spine, Inc., B. Braun Melsungen, SIGNUS Medizintechnik GmbH, Aditus Medical, RTI Surgical, Orthofix Medical Inc., Premia Spine, Globus Medical, SpineSave AG, Centinel Spine®, LLC, AxioMed LLC., Spinal Stabilization Technologies Ltd., SpineVision, Norm Medical Devices Co. Ltd., Neuro France Implants, and Ackermann Medical GmbH & Co. KG, among others.

To know more about why North America is leading the market growth in the Spinal Non-Fusion Devices Market, Get a snapshot @https://www.delveinsight.com/sample-request/spinal-non-fusion-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Spinal Non Fusion Devices Overview

Spinal non-fusion devices are designed to maintain or restore spinal function and flexibility while alleviating pain, offering an alternative to traditional spinal fusion surgeries. These devices are less invasive and cater to patients with various spinal disorders who seek to avoid the long-term complications associated with fusion procedures, typically requiring less invasive surgical techniques that lead to quicker recovery and reduced hospital stays.

Spinal Non Fusion Devices Market Key Growth Drivers

- The World Health Organization (2024) reports that globally, over 15 million people are living with spinal cord injury (SCI), a significant cause of long-term disability, with SCI accounting for more than 4.5 million years of life lived with disability (YLDs) in 2021.
- The Global Burden of Disease (2023) projects that by 2050, 840 million people will suffer from lower back pain, sustaining long-term demand for non-fusion treatment alternatives.
- The Australian Institute of Health and Welfare (2024) estimated that around 4.0 million people, or 16% of Australia's population, were living with back problems in 2022, with 177,000 hospitalizations for back problems recorded during 2021-2022.
- Non-fusion devices align with increasing patient preference for treatments that minimize surgical risk and recovery time, as annulus fibrosus injury from herniation and degeneration can lead to accelerated degeneration and prolonged chronic pain requiring surgical intervention.
- Continued regulatory approvals are expanding treatment options, including Johnson & Johnson MedTech's October 2023 FDA 510(k) clearances for the TriALTISTM Spine System and Navigation Enabled Instruments, designed to address spinal disorders while preserving motion and function.
- Active strategic and clinical investigation activity among key players, including Orthofix Medical's first patient implant in its M6-C Artificial Cervical Disc Two-Level IDE Study in August 2021, is expected to propel the market in the forthcoming years.
- The expansion of treatment options and increased competition among manufacturers is enhancing patient outcomes and propelling market growth through 2030.

Get a sneak peek at the Spinal Non-Fusion Devices Market Dynamics @https://www.delveinsight.com/sample-request/spinal-non-fusion-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Spinal Non Fusion Devices Market Segment Analysis

The Spinal Non-Fusion Devices Market by Product Type (Artificial Disc [Lumbar and Cervical], Dynamic Stabilization Devices, Facet Replacement Products, and Others), Application (Spinal Stenosis, Degenerative Disc Diseases, Spondylolisthesis, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

By Product Type: The Artificial Disc segment is expected to hold the largest share of approximately 58.99% in 2023, reflecting the wide applications and advantages of lumbar and cervical artificial discs. Artificial disc replacement aims to alleviate pain by reducing aggravating micromotion, stabilizing the spinal segment, and minimizing inflammation, with lumbar artificial discs available in constrained and unconstrained designs and cervical artificial discs eliminating the need for bone graft and spinal instrumentation while allowing quicker return to neck movement after surgery.

By Geography: North America is expected to hold the largest share of approximately 59.57% in 2023, driven by the rising geriatric population, increasing incidence of spinal disorders, government initiatives, and expanding product regulation. The American Cancer Society (2024) estimated about 25,400 malignant tumors of the brain or spinal cord diagnosed in the U.S. in 2023, and the United States Bone and Joint Initiative (2023) reports that musculoskeletal diseases affect more than half of U.S. adults, with 12% to 14% of the adult population visiting a physician for back pain annually. Johns Hopkins University data further indicates approximately 3 million new scoliosis cases are diagnosed annually in the U.S., predominantly in adolescents aged 10 to 12.

Which MedTech key players in the Spinal Non-Fusion Devices Market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/sample-request/spinal-non-fusion-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Spinal Non Fusion Devices Market Restraints

Despite steady momentum, the Spinal Non-Fusion Devices market faces material constraints. The availability of alternative products and slow adoption due to limited clinical evidence may impede market growth during the forecast period.

Interested in knowing the Spinal Non-Fusion Devices Market by 2030? Click to get a snapshot of the Spinal Non-Fusion Devices Market Trends-https://www.delveinsight.com/sample-request/spinal-non-fusion-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Scope of the Spinal Non Fusion Devices Market Report

- Coverage- Global
- Study Period- 2020 to 2030
- Forecast Period- 2024-2030
- Spinal Non-Fusion Devices Companies- Stryker, NuVasive Inc., Medtronic, Zimmer Biomet, ATEC Spine, Inc., B. Braun Melsungen, SIGNUS Medizintechnik GmbH, Aditus Medical, RTI Surgical, Orthofix Medical Inc., Premia Spine, Globus Medical, SpineSave AG, Centinel Spine®, LLC, AxioMed LLC., Spinal Stabilization Technologies Ltd., SpineVision, Norm Medical Devices Co. Ltd., Neuro France Implants, Ackermann Medical GmbH & Co. KG, and others.
- Spinal Non-Fusion Devices Market Restraints and Regulatory Analysis
- Spinal Non-Fusion Devices Porter Five Forces Analysis and Market Assessment

Explore more information of the Spinal Non-Fusion Devices Market Insights @https://www.delveinsight.com/sample-request/spinal-non-fusion-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Table of Contents

1. Spinal Non Fusion Devices Market Report Introduction
2. Spinal Non Fusion Devices Market Executive Summary
3. Spinal Non Fusion Devices Competitive Landscape
4. Spinal Non Fusion Devices Regulatory Analysis
5. Spinal Non Fusion Devices Market Key Factors Analysis
6. Spinal Non Fusion Devices Market Porter's Five Forces Analysis
7. Spinal Non Fusion Devices Market Assessment
8. Spinal Non Fusion Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

Company Name: DelveInsight Business Research LLP
Contact Person: Kanishk Kumar
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

This release was published on openPR.